Biocryst Pharmaceuticals Inc (BCRX) Com Stk USD 0.01
0.38%- This stock can be held in a
Stocks and Shares ISASell:$7.92
Buy:$7.93
Change:
$0.30
(3.85%)
$0.30
(3.85%)Market closed | Prices delayed by at least 15 minutes
Sell:$7.92
Buy:$7.93
Change:$0.30
(3.85%)
$0.30
(3.85%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 19 December 2024 | Jon P StonehousePresident/CEO | Sell Tax related | 14,010 | $7.39 | $103,533.90 | 1,449,109 |
| 19 December 2024 | Charles K. (Charlie) GayerChief Level Officer | Sell Tax related | 2,461 | $7.39 | $18,186.79 | 423,546 |
| 19 December 2024 | Alane P BarnesChief Legal/Compliance Officer | Sell Tax related | 2,461 | $7.39 | $18,186.79 | 412,729 |
| 19 December 2024 | Helen M ThackrayChief Level Officer | Sell Tax related | 6,096 | $7.39 | $45,049.44 | 384,843 |
| 19 December 2024 | Anthony DoyleCFO | Sell Tax related | 2,461 | $7.39 | $18,186.79 | 377,867 |
| 14 December 2024 | Jon P StonehousePresident/CEO | Sell Tax related | 27,525 | $7.53 | $207,263.25 | 1,101,019 |
| 14 December 2024 | Charles K. (Charlie) GayerChief Level Officer | Sell Tax related | 8,251 | $7.53 | $62,130.03 | 300,057 |
| 14 December 2024 | Alane P BarnesChief Legal/Compliance Officer | Sell Tax related | 8,613 | $7.53 | $64,855.89 | 294,490 |
| 14 December 2024 | Helen M ThackrayChief Level Officer | Sell Tax related | 7,150 | $7.53 | $53,839.50 | 264,989 |
| 14 December 2024 | Anthony DoyleCFO | Sell Tax related | 7,890 | $7.53 | $59,411.70 | 259,628 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 14 December 2024 | Jon P StonehousePresident/CEO | Sell Tax related | 27,525 | $7.53 | $207,263.25 | 1,101,019 |
| 14 May 2024 | Anthony DoyleCFO | Buy Regular purchase transaction | 36,300 | $5.57 | $202,191.00 | 266,744 |
| 14 May 2024 | Helen M ThackrayChief Level Officer | Buy Regular purchase transaction | 30,000 | $5.86 | $175,800.00 | 272,139 |
| 13 May 2024 | Jon P StonehousePresident/CEO | Buy Regular purchase transaction | 30,000 | $5.55 | $166,500.00 | 1,127,770 |
| 13 May 2024 | Charles K. (Charlie) GayerChief Level Officer | Buy Regular purchase transaction | 30,000 | $5.47 | $164,100.00 | 307,533 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.